Grade: Pharmaceutical Grade
Pharmaceutical Intermediates Critical pharmaceutical intermediate for the commercial synthesis of Fluconazole, a widely prescribed broad-spectrum antifungal API.
2,4-Difluoro-alpha-(1H-1,2,4-triazolyl)acetophenone (DFTA), CAS No. 86404-63-9, is a key pharmaceutical intermediate used in the synthesis of Fluconazole and related azole antifungal APIs. Dexter Industries supplies DFTA with a focus on product consistency, applicable specifications and reliable documentation support.
| CAS Number | 86404-63-9 |
|---|---|
| IUPAC Name | 2-(1H-1,2,4-triazol-1-yl)-1-(2,4-difluorophenyl)ethan-1-one |
| Molecular Formula | C10H7F2N3O |
| Molecular Weight | 223.18 g/mol |
| Assay / Purity | [TO BE CONFIRMED — verify assay spec with technical team] |
| Physical Appearance | White to pale yellow powder |
| Melting Point / Range | 104 - 106 °C |
| Grade | Pharmaceutical Grade |
| Supply Capacity | [TO BE CONFIRMED] |
CORE PRODUCT RCMH · CAS 181289-33-8
Key chiral intermediate for the commercial synthesis of the anticonvulsant and neuropathic pain API Pregabalin.
Pregabalin (API) Commercial Synthesis, Anticonvulsant & Neuropathic Pain Formulations, Chiral Asymmetric Synthesis
KEY INTERMEDIATE CMH · CAS 181289-15-6
Primary racemic intermediate widely used in multi-step chemical synthesis of Pregabalin.
Pregabalin API Precursor Synthesis, Racemic Chemical Processing, Anticonvulsant & Neurological Medication Production
PHARMA INTERMEDIATE 4-TACH · CAS 27489-62-9
Key pharmaceutical intermediate used in the synthesis of Ambroxol, a widely used mucolytic API for respiratory therapy.
Ambroxol API Synthesis (Mucolytic / Respiratory), Advanced Pharmaceutical Intermediate Synthesis, Chemical Building Block for API Manufacturing
